Last edition
News about "India pharma exports to USD 65 billion by 2030"
India's Pharma Sector Shows Strategic Maturity Amid Global Tariff Shocks: Rubix Report
In this dynamic environment, Rubix Data Sciences, a leading provider of risk management and compliance monitoring solutions, has released a comprehensive industry report that captures how Indian pharmaceutical companies are navigating volatility by focusing on complex generics, regulatory strength, and global expansion.
India Pharma Exports To USD 65 Billion By 2030 | 24/07/2025 | By Darshana | 246
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy